Strategies for Improving Rapid Influenza Testing and Treatment in Ambulatory Settings (SIRAS) | Joint Commission
Follow us on Twitter Friend us on Facebook Vimeo linkedIn Share with your Friends Print this Page
 
Saturday 3:45 CST, June 24, 2017

Strategies for Improving Rapid Influenza Testing and Treatment in Ambulatory Settings (SIRAS)

SIRAS

Now available!

  • Updated for the current Flu Season
  • Improved Course Design
    • Four short, 30-minute courses
    •  Free CE credits
    • Ability to view and print transcripts anytime
  • Available on I-pads & Tablets
  • Easy access to videos & resources 
  • Enroll in the course
shareslide1

NUEVO!  SIRAS en español

English

Español

    Enroll Now - Top      enroll-now-button-spanish_200x37   

              

Did you know? 

Seasonal influenza affects 5% to 20% of the population each year in the United States, and is associated with more than 200,000 hospitalizations each year.

  • Healthy people are at risk of complications from influenza too, not just those with chronic illness and vulnerable populations.

  • You do NOT need to order a Rapid Influenza Diagnostic Test (RIDT) for every patient who exhibits flu symptoms in order to make a diagnosis of influenza.

  • Influenza antiviral drugs play an important role in treating flu illnesses.  Early antiviral treatment works best.


How is Your Practice Handling the Flu Season? 

  • Learn WHEN to order a Rapid Influenza Diagnostic Test (RIDT)

  • Know HOW to interpret RIDT results

  • Understand HOW to use local epidemiological information, clinical presentation and RIDT results to assist with the diagnosis and treatment of influenza in your practice setting

  • Learn HOW to properly collect respiratory samples for influenza testing

Stay up-to-date on CDC flu surveillance.

 Note:


The Joint Commission and the Centers for Disease Control and Prevention would like to thank Copan Diagnostics for their contribution in producing these instructional videos.

This acknowledgement is not an endorsement or recommendation of any specific commercial product by The Joint Commission or the Centers for Disease Control and Prevention.

Fuente del contenido: Centros para el Control y la Prevención de Enfermedades, traducido por CDC Multilingual Services #263871-C.

Continuing Education Credit

Joint Accreditation Statement
The Joint Commission is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE)* and the Accreditation Council for Continuing Medical Education (ACCME- AMA PRA Category 1 Credits™), to provide continuing education for the healthcare team.

*This course does not offer ACPE continuing education credit.

This educational module is approved for 2.0 Continuing Education Credit from:

  • Accreditation Council for Continuing Medical Education (ACCME- AMA PRA Category 1 Credits™)
  • American Nurses Credentialing Center (ANCC)
  • American College of Healthcare Executives (ACHE)
  • California Board of Registered Nursing
  • International Association for Continuing Education and Training (IACET)
  • American Society of Clinical Laboratory Science PACE (ASCLS PACE)

In order to claim the credits, you must:

  • Individually register for the module
  • Complete the module
  • Complete the post course evaluation
  • Score a passing grade on the post course exam